The latest research, clinical data and innovations in
ophthalmology were presented at the 2019 Annual Meeting of the American Academy
of Ophthalmology (AAO) in San Francisco, USA, held on 12−15 October 2019. As in
previous years, an international panel of renowned ophthalmologists attended
the meeting and contributed articles to Eye on AAO 2019 – an e-Bulletin series featuring
research highlights and hot topics presented at the meeting, with commentaries
on their relevance to clinical practice in the Asia Pacific and Latin American regions.
At a recent Boehringer Ingelheim-sponsored symposium held in conjunction with the 10th Malaysian Endocrine and Metabolic Society Annual Congress, two distinguished speakers spoke on the latest updates in glucose-lowering therapy for the treatment for type 2 diabetes mellitus (T2DM) and highlighted some important cardiovascular outcome trial results of these antidiabetic agents.
At the recent Takeda Malaysia Vocinti® (vonoprazan) launch, held in conjunction with the Annual Scientific Meeting of the Malaysian Society of Gastroenterology and Hepatology - GUT 2019 at Shangri-La Kuala Lumpur, Professor Akihito spoke about vonoprazan’s merits as an alternative to conventional proton pump inhibitors.
The incidence of prostate cancer (PC) and cardiovascular disease (CVD) typically increases with age; therefore, the choice of treatment for PC should take into account a patient’s underlying cardiovascular conditions. In this interview, Professor Laurence Klotz shared his take on androgen deprivation therapy (ADT) options for patients with prostate cancer who are at-risk of CV events.
Pertussis is a highly contagious respiratory illness caused by Bordetella pertussis. Despite the introduction of effective infant immunisation programmes and high vaccination coverage, pertussis remains a public health concern.1 Recently, MIMS Doctor spoke to Dato’ Dr Musa Mohd Nordin who gave us some insights into the resurgence of pertussis in Malaysia, highlighting strategies to further strengthen the current vaccine coverage rate (VCR).
At the A. Menarini-sponsored symposium, held during the 8thAssociation of South-East Asian Pain Societies (ASEAPS)Congress at Pullman Hotel Kuching, Malaysia, the importance ofa multidisciplinary approach in the management of osteoarthritis(OA) was discussed. A distinguished panel of speakers reviewedthe role of various types of treatments in the management of OAthrough a hypothetical patient case scenario, and shared theirinsights into some questions commonly asked by physicians,including their recommended strategies for pre- and postsurgeryanaesthesia and analgesia
Influenza infection is often times underrecognised and underdiagnosed in Malaysia even though it may occur at anytime of the year, unlike in temperate countries. Smoking is a well-established risk factor for influenza infection, and it is associated with a more severe disease course, morbidity and mortality. The National Avian Influenza Surveillance System of Thailand reported that current or former smoking is among the risk factors associated with a fatal outcome in patients with influenza.
Topical silicone gel is considered first-line therapy against scars and is used particularly for the treatment of elevated scars,such as hypertrophic and keloid scars. In this report, Dr Yong shares his clinical experience of using silicone gel as part of his scar management strategies.
Jointly organized by the Malaysian Medical Associationand AstraZeneca to commemorate the launch of QTERN,the Q-UEST Symposium saw three distinguished speakersproviding valuable insights into the landscape of T2DMin Malaysia and discussing the latest treatment optionsavailable in the country.
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.